Clinical trials of vaccine against coronavirus planned in Uzbekistan
22/10/2020 11:10
Clinical trials of vaccine against coronavirus planned in Uzbekistan
22/10/2020 11:10
Tashkent, Uzbekistan (UzDaily.com) -- On 21 October this year, the Ministry of Innovative Development held negotiations with representatives of the Institute of Microbiology of the Chinese Academy of Sciences and the Chinese company Anhui Zhifei Longcom Biopharmaceutical to organize clinical trials of a recombinant vaccine against coronavirus in Uzbekistan.
The vaccine, developed by this company and currently undergoing clinical trials, is a genetically engineered protein of the surface antigen of the coronavirus, which has a high degree of safety compared to adenovirus and inactivated types of vaccines.
During the negotiations, it was noted that in case of successful completion of all phases of clinical trials, Uzbekistan will have priority in purchasing the vaccine in terms of timing and minimum price.
Specialists from the Ministry of Innovative Development discussed with Chinese partners the organization of the vaccination process and preparation for this process. The clinical trials are expected to be conducted on volunteers 18 years of age and older. Before the start of the trial, representatives of the People’s Republic of China will conduct a series of trainings on vaccination conditions.
25/04/2024Read more
$ 1 | 12697.00 | 0.000% |
1 | 13547.70 | 0.000% |
₽ 1 | 135.05 | 0.000% |